Genesis Healthcare

Zanesville, Ohio 43701

0 studies enrolling now · 3 studies all time

What they study most

Blood Coagulation, HER2-negative Breast Cancer, Stress Urinary Incontinence

Studies at this site

• Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence — Completed
• Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling — Status unconfirmed
• Safety of Oral Anticoagulants Registry — Status unconfirmed